Metraipolis › archive › dc_de0d7ec02a2e

Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report — Europe PMC PMID:42222121

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42222121
DOI
10.3389/fcvm.2026.1805200
License (as archived)
solo-consultazione
Archived
2026-11-02T06:31:06.425Z
SHA-256 of the archived text
23f56d336d27b253084ac0895f44cac93a3a26e8c8d38059eb28b1e92753b047
Stable URL of this page
https://metraipolis.com/documento/dc_de0d7ec02a2e

How to cite

Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report — Europe PMC PMID:42222121 — Europe PMC (en), https://europepmc.org/article/MED/42222121 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de0d7ec02a2e (Metraipolis archive dc_de0d7ec02a2e, sha256 23f56d336d27b253084ac0895f44cac93a3a26e8c8d38059eb28b1e92753b047)
BibTeX
@misc{dcde0d7ec02a2e,
  title = {Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report — Europe PMC PMID:42222121},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42222121},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de0d7ec02a2e; sha256 23f56d336d27b253084ac0895f44cac93a3a26e8c8d38059eb28b1e92753b047},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222121. Agents can read the archived copy with the MCP tool read_document.